FT

AstraZeneca on track to submit data for US vaccine approval, says chief

Pharma group plans filing in next few weeks after controversy over previous trial results

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button